PartsTable
Technical Data Sheet
Download PDF

NDC00186-0175-14 — LIDOCAINE HYDROCHLORIDE AND EPIN

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00186-0175-14: LIDOCAINE HYDROCHLORIDE AND EPIN.

LIDOCAINE HYDROCHLORIDE AND EPIN. Key specifications include special_features: EPINEPRINE 1:100,000, supplementary_features: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 100, primary_container_content_quantity: 1.800 MILLILITERS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-146-1139, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00186-0175-14
NSN: 6505-01-146-1139
FSC: 6505 — Drugs and Biologicals
CAGE: 04473 — ASTRA PHARMACEUTICALS LP (USA)
SPECIFICATIONS
special_featuresEPINEPRINE 1:100,000
supplementary_featuresD-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity100
primary_container_content_quantity1.800 MILLILITERS
active_medicament_medicinal_strength0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
NSN6505-01-146-1139
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available LIDOCAINE HYDROCHLORIDE AND EPIN TITLE COMPONENT PN NDC00186-0175-14 MFR LIDOCAINE HYDROCHLORID
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS
•
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: CARTRIDGE
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY1.800 MILLILITERS
SUPPLEMENTARY FEATURESD-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPECARTRIDGE
SPECIAL FEATURESEPINEPRINE 1:100,000
PART NAME ASSIGNED BY CONTROLLING AGENCYLIDOCAINE HYDROCHLORIDE & EPINEPHRINE INJ USP 1.8ML CARTRIDGE 100S
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY100
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
XYLOCAINE ASTRAPAKReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
HAZMAT per U.S. Government catalogNo demilitarization required
Ready to buy NDC00186-0175-14?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00186-0175-14?
NDC00186-0175-14 is a LIDOCAINE HYDROCHLORIDE AND EPIN.
What parts can replace NDC00186-0175-14?
There is 1 known substitute for NDC00186-0175-14: XYLOCAINE ASTRAPAK. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00186-0175-14?
NDC00186-0175-14 is cataloged in the U.S. Government catalog under NSN 6505-01-146-1139. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00186-0175-14